Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
J Cosmet Dermatol ; 18(5): 1389-1394, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30636339

ABSTRACT

BACKGROUND: Traditional medicine herbal prescriptions used for the treatment of skin disease have been developed into cosmetics. Sang-Hyul-Yun-Boo-Em (SHYBE) is a mixed herbal formula prescribed for patients with yin or blood deficiency patterns of skin disease. A previous study reported that SHYBE exercises anti-allergic and anti-inflammatory effects. To date, no study has reported the efficacy of cosmetics containing the SHYBE extract. AIMS: To observe the efficacy of SHYBE extract cream on hydration, elasticity, thickness, and dermis density in aged skin. METHODS: This was a double-blind randomized placebo-controlled parallel-group trial. The trial consisted of an 8-week topical application of the test or placebo products with two visits at 4-week intervals. A total of 46 healthy Korean females, aged 40-59, were enrolled in this study. Objective skin assessments for hydration, elasticity, thickness and dermis density, self-assessment, and safety assessment were conducted. RESULTS: Sang-Hyul-Yun-Boo-Em extract cream improved skin hydration, elasticity, and dermal density in Asian middle-aged females compared with placebo cream, which excluded SHYBE extract and contained other cosmetic materials. CONCLUSIONS: Sang-Hyul-Yun-Boo-Em extract cream showed anti-aging properties in middle-aged women. It could be recommended for aging skin with dryness, and loss of elasticity and density.

2.
Nat Prod Res ; 32(24): 2945-2949, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29034737

ABSTRACT

Vanillic acid, which is well known as a benzoic acid derivative, has been used as a flavouring agent. Currently, we ascertained the therapeutic potential action of vanillic acid on allergic inflammatory reaction in human mast cell line, HMC-1. Treatment with vanillic acid resulted in a significant decrease in levels of thymic stromal lymphopoietin and pro-inflammatory cytokines compared to phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)-treated HMC-1 cells. In PMACI-stimulated cells, treatment with vanillic acid also dramatically inhibited activities of caspase-1 and nuclear factor-kB (p65). Furthermore, treatment with vanillic acid suppressed phosphorylation of mitogen-activated protein kinases in PMACI-treated HMC-1 cells. Taken together, these findings suggest that vanillic acid has a beneficial effect on allergic inflammatory disorders.


Subject(s)
Anti-Allergic Agents/pharmacology , Cytokines/metabolism , Mast Cells/drug effects , Vanillic Acid/pharmacology , Caspase 1/drug effects , Caspase 1/metabolism , Cell Line , Humans , Inflammation/drug therapy , Mast Cells/metabolism , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , Phosphorylation/drug effects , Vanillic Acid/therapeutic use , Thymic Stromal Lymphopoietin
3.
Food Chem Toxicol ; 106(Pt A): 78-85, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28545868

ABSTRACT

Atractylenolide III (ATL-III) is an active compound of Atractylodes lancea, which has been widely used for the treatment of cancer. Cancer is closely connected with inflammation, and many anti-inflammatory agents are also used to treat cancer. We investigated the influence of ATL-III on thymic stromal lymphopoietin (TSLP)-induced inflammatory reactions. Pretreatment with ATL-III suppressed murine double minute 2 levels and promoted p53 levels in TSLP-treated human mast cell, HMC-1 cells. Mast cell proliferation increased by TSLP or IL-3 stimulation was significantly decreased by ATL-III pretreatment. Interleukin (IL)-13 and phosphorylated signal transducer and activator of transcription 3, 5, and 6 levels in TSLP-treated HMC-1 cells were also decreased by ATL-III pretreatment. In addition, ATL-III decreased the TSLP-induced production of proinflammatory cytokines (IL-6, IL-1ß, tumor necrosis factor-α, and IL-8). ATL-III decreased the levels of Bcl2 and procaspase-3 and increased caspase-3 activation and cleaved PARP levels. Furthermore, ATL-III decreased TSLP-induced mast cell proliferation and the production of inflammatory cytokine by LAD2 cells. Taken together, these findings suggest that ATL-III plays a useful role as an anti-inflammatory agent and should be viewed as a potential anti-cancer agent.


Subject(s)
Atractylodes/chemistry , Cell Proliferation/drug effects , Cytokines/pharmacology , Lactones/pharmacology , Mast Cells/cytology , Plant Extracts/pharmacology , Sesquiterpenes/pharmacology , Anti-Inflammatory Agents/pharmacology , Caspase 3/genetics , Caspase 3/metabolism , Cell Line , Humans , Interleukin-13/genetics , Interleukin-13/metabolism , Mast Cells/drug effects , Mast Cells/metabolism , Phosphorylation , Proto-Oncogene Proteins c-mdm2/genetics , Proto-Oncogene Proteins c-mdm2/metabolism , STAT6 Transcription Factor/genetics , STAT6 Transcription Factor/metabolism , Thymic Stromal Lymphopoietin
4.
Biol Pharm Bull ; 39(1): 90-6, 2016.
Article in English | MEDLINE | ID: mdl-26725432

ABSTRACT

Cordycepin (3'-deoxyadenosine) is one of the active components isolated from Cordyceps militaris, and has been shown to have anti-inflammatory, anti-oxidant, anti-aging, and anti-cancer effects. Mast cell-derived thymic stromal lymphopoietin (TSLP) plays an important role in the pathogenesis of allergic inflammatory reactions. Here, we investigated the regulatory effect and mechanisms of cordycepin on the expression of TSLP in the human mast cell line, HMC-1 cells, and in the human keratinocyte cell line, HaCaT cells. Cordycepin significantly decreased the production and mRNA expression of TSLP through the inhibition of caspase-1 and nuclear factor-κB activation. Cordycepin also significantly reduced the phosphorylation of receptor-interacting protein 2 and inhibitory kappa B (IκB) kinase ß. Cordycepin significantly decreased the production and mRNA expression of interleukin (IL)-8, IL-1ß, IL-6, and tumor necrosis factor-α in activated HMC-1 cells. Moreover, cordycepin significantly decreased the levels of TSLP in activated HaCaT cells. Our studies suggest that cordycepin can be applied to the treatment of allergic inflammatory diseases exacerbated by TSLP.


Subject(s)
Caspase 1/metabolism , Cytokines/metabolism , Deoxyadenosines/pharmacology , Gene Expression Regulation/drug effects , Mast Cells/drug effects , Receptor-Interacting Protein Serine-Threonine Kinase 2/metabolism , Calcimycin/pharmacology , Caspase 1/genetics , Cell Line , Cytokines/genetics , Humans , I-kappa B Kinase , Keratinocytes/drug effects , Keratinocytes/metabolism , NF-kappa B , Receptor-Interacting Protein Serine-Threonine Kinase 2/genetics , Signal Transduction/physiology , Tetradecanoylphorbol Acetate/pharmacology , Thymic Stromal Lymphopoietin
5.
Life Sci ; 144: 49-53, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26631504

ABSTRACT

AIMS: Acne is a common skin disease that originates in the sebaceous gland. The pathogenesis of acne is very complex, involving the increase of sebum production and perifollicular inflammation. In this study, we screened the anti-lipogenic material and demonstrated its effect using cultured human sebocytes. MAIN METHODS: Normal human sebocytes were cultured by explanting the sebaceous glands. To evaluate the anti-lipogenic effect, sebocytes were treated with test materials and (14)C-acetate incorporation assay was performed. KEY FINDINGS: To screen the anti-lipogenic materials, we tested the effect of many herbal plant extracts. We found that Angelica dahurica extract inhibited the insulin-like growth factor-1 (IGF-1)-induced sebum production in terms of squalene synthesis in sebocytes. Furthermore, imperatorin isolated from A. dahurica showed remarkable inhibitory effect on squalene production as well as squalene synthase promoter activity. To investigate the putative action mechanism, we tested the effect of imperatorin on intracellular signaling. The results showed that imperatorin inhibited IGF-1-induced phosphorylation of Akt. In addition, imperatorin significantly down-regulated PPAR-γ and SREBP-1, the important transcription factors for lipid synthesis. SIGNIFICANCE: These results suggest that imperatorin has a potential for reducing sebum production in sebocytes, and can be applicable for acne treatment.


Subject(s)
Furocoumarins/pharmacology , Insulin-Like Growth Factor I/antagonists & inhibitors , Insulin-Like Growth Factor I/pharmacology , Sebum/metabolism , Angelica/chemistry , Cells, Cultured , Farnesyl-Diphosphate Farnesyltransferase/antagonists & inhibitors , Farnesyl-Diphosphate Farnesyltransferase/drug effects , Farnesyl-Diphosphate Farnesyltransferase/genetics , Humans , Lipogenesis/drug effects , Phosphorylation/drug effects , Plant Extracts/pharmacology , Proto-Oncogene Proteins c-akt/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Sebaceous Glands/cytology , Sebaceous Glands/drug effects , Sebaceous Glands/metabolism , Sebum/drug effects , Skin/cytology , Skin/drug effects , Skin/metabolism , Squalene/metabolism
6.
Ann Dermatol ; 25(3): 315-20, 2013 Aug.
Article in English | MEDLINE | ID: mdl-24003274

ABSTRACT

BACKGROUND: The fibrous proteins of extracellular matrix (ECM) produced by dermal fibroblast contributes to the maintenance of connective tissue integrity. OBJECTIVE: This study is carried out to identify the bioactive ingredient from natural products that enhances ECM production in dermal fibroblasts. METHODS: Bioassay-directed fractionation was used to isolate the active ingredient from natural extracts. The effects of rasatiol (isolated from Raphanus sativus) on ECM production in primary cultured human dermal fibroblasts was investigated by enzyme linked immunosorbent assay and western blot analysis. RESULTS: Rasatiol accelerated fibroblast growth in a dose-dependent manner and increased the production of type 1 collagen, fibronectin and elastin. Phosphorylation of p42/44 extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and Akt was remarkably increased by rasatiol, indicating that enhanced ECM production is linked to the activation of intracellular signaling cascades. CONCLUSION: These results indicate that rasatiol stimulates the fibrous components of ECM production, and may be applied to the maintenance of skin texture.

7.
Ann Dermatol ; 24(1): 16-21, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22363150

ABSTRACT

BACKGROUND: The extracellular matrix (ECM) produced by dermal fibroblasts supports skin structure, and degradation and/or reduced production of ECM are the main causes of wrinkle formation. OBJECTIVE: The aim of this study was to identify the active ingredient that enhances ECM production in dermal fibroblasts. METHODS: Polarity-based fractionation was used to isolate the active ingredient from natural extracts, and the effects of cedrol (isolated from Pterocarpus indicusirginia) on ECM production in cultured human dermal fibroblasts was investigated by reverse transcription-polymerase chain reaction, enzyme linked immunosorbent assay, and Western blot analysis. RESULTS: Cedrol accelerated fibroblast growth in a dose-dependent manner and increased the production of type 1 collagen and elastin. Phosphorylation of p42/44 extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and Akt was markedly increased by cedrol, indicating that enhanced ECM production is linked to activation of intracellular signaling cascades. CONCLUSION: These results indicate that cedrol stimulates ECM production, with possible applications to the maintenance of skin texture.

8.
Int J Mol Med ; 29(2): 195-201, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22020741

ABSTRACT

Hair regression and balding are distressing concerns for an increasing number of people due to changes in lifestyle and serious nutritional imbalances. Therapies for treatment of hair loss are needed. Among potential therapeutics, adenosine has been suggested as a potent regulator of hair growth. In this study, we investigated the effects of adenosine on hair follicles and dermal papilla (DP) cells, and the mechanism underlying the action of adenosine. Hair follicles are organs, including DP cells, that are responsible for the production of hair fibers by inducing and maintaining the hair growth phase (anagen). In a culture of DP cells in vitro, adenosine stimulated proliferation of DP cells by increasing thymidine uptake. Subsequently, adenosine activated and elongated the anagen phase by increasing the uptake of radiolabeled cysteine in an organ culture of mouse vibrissae hair follicles. We also confirmed that adenosine promoted the expression of several growth factors that are responsible for hair growth, including fibroblast growth factors (FGF)-7, FGF-2, insulin-like growth factor (IGF)-1, and vascular endothelial growth factor (VEGF) in a cDNA microarray with semi-quantitative RT-PCR. Transcriptional activation of ß-catenin in DP cells was increased by adenosine in a luciferase assay. ß-catenin is a co-activator of Wnt/ß-catenin signaling that induces morphogenesis and differentiation of hair follicles and also acts to transactivate downstream signaling pathways, including the ERK pathway. Using Western blotting, we found that adenosine stimulated phosphorylation of ERK, CREB and AKT. These results suggest that adenosine stimulates growth of hair follicles by triggering the expression of growth factors and ß-catenin, and by inducing their downstream target signaling pathways.


Subject(s)
Adenosine/pharmacology , Cysteine/metabolism , Dermis/growth & development , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 7/genetics , Hair Follicle/drug effects , Hair Follicle/growth & development , Animals , Cell Differentiation/drug effects , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/metabolism , Dermis/drug effects , Dermis/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Expression Regulation/drug effects , Hair Follicle/metabolism , Humans , Mice , Mice, Inbred C57BL , Organ Culture Techniques/methods , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Thymidine/metabolism , Vibrissae/cytology , beta Catenin/genetics
9.
Ann Dermatol ; 22(2): 173-9, 2010 May.
Article in English | MEDLINE | ID: mdl-20548908

ABSTRACT

BACKGROUND: Fibroblasts produce many components of the extracellular matrix (ECM) and so they contribute to the maintenance of connective tissue integrity. OBJECTIVE: The aim of this study is to evaluate the effect of velvet antler extract (VAE) on the ECM production of dermal fibroblasts cultured in vitro. METHODS: Primary cultured human dermal fibroblasts were treated with VAE, and then the ECM production was determined by RT-PCR, ELISA and Western blot analysis. Furthermore, the change of gene expression according to VAE treatment was evaluated by cDNA microarray. RESULTS: VAE accelerated the growth of fibroblasts in a dose-dependent manner. VAE increased the production of several ECM components, including type 1 collagen, fibronectin and elastin. In line with these results, the phosphorylations of p42/44 ERK and p38 mitogen-activated protein kinase were markedly increased by VAE, suggesting that the enhancement of ECM production may be linked to the activation of intracellular signaling cascades. VAE also significantly increased cell migration on an in vitro scratch wound test. In cDNA microarray, many genes related with connective tissue integrity were identified to be up-regulated by VAE. CONCLUSION: These results suggest that VAE has a potential to stimulate ECM production, and VAE may be applicable for maintaining the skin's texture.

10.
Exp Dermatol ; 17(8): 693-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18312387

ABSTRACT

Cyclosporin A (CsA) has been used as a potent immunosuppressive agent for inhibiting the graft rejection after organ transplantation. However, CsA provokes lots of side effects including hirsutism, the phenomenon of abnormal hair growth in the body. In the present study, we investigated the hair growth stimulating effect of CsA using in vivo and in vitro test models. When topically applied on the back skin of mice, CsA induced fast telogen to anagen transition. In contrast, CsA had no effect on the growth of human hair follicle tissues cultured in vitro, indicating that it might not have the mitogenic effect on hair follicles. To identify the genes related with CsA-induced hair growth, we performed differential display RT-PCR. Among the genes obtained, the expression of synapse associated protein 102 (SAP102) was verified using competitive RT-PCR. The result showed that the expression of SAP102 was significantly induced by CsA treatment in the back skin of C57BL/6 mice. However, the increase of SAP102 mRNA was also seen in spontaneous anagen mice, suggesting that induction of SAP102 is one event of the anagen hair growth response regardless of how the growth state was induced. SAP102 was not expressed in cultured human hair outer root sheath and dermal papilla cells. Immunohistochemistry analysis showed that CsA induced the expression of SAP102 in perifollicular region of mouse anagen hair. Together, these results suggest that SAP102 is one of hair-cycle-dependent genes, whose expression is related with the anagen progression.


Subject(s)
Cyclosporine/pharmacology , Hair/drug effects , Hair/growth & development , Neuropeptides/genetics , Animals , Base Sequence , Cells, Cultured , Cyclosporine/administration & dosage , DNA Primers/genetics , Female , Gene Expression/drug effects , Gene Expression Profiling , Guanylate Kinases , Hair/metabolism , Humans , Immunohistochemistry , Membrane Proteins , Mice , Mice, Inbred C57BL , Neuropeptides/metabolism , Reverse Transcriptase Polymerase Chain Reaction
11.
J Steroid Biochem Mol Biol ; 107(3-5): 245-52, 2007.
Article in English | MEDLINE | ID: mdl-17646096

ABSTRACT

Dihydrotestosterone (DHT) is the most potent male hormone that causes androgenetic alopecia. The type II 5alpha-reductase is an enzyme that catalyzes the conversion of testosterone (T) to DHT, therefore it can be expected that specific inhibitors for type II 5alpha-reductase may improve the pathophysiologic status of androgenetic alopecia. In this study, we attempted to establish the reliable and convenient screening model for type II 5alpha-reductase inhibitors. After transfection of human cDNA for type II 5alpha-reductase into HEK293 cells, the type II 5alpha-reductase over-expressing stable cells were selected by G418 treatment. RT-PCR and Western blot analyses confirmed that type II 5alpha-reductase gene was expressed in the stable cells. In in vitro enzymatic assay, 10 microg of stable cell extract completely converted 1 microCi (approximately 0.015 nmol) of T into DHT. The type II 5alpha-reductase activity was inhibited by finasteride in a dose-dependent manner, confirming the reliability of screening system. In cell culture condition, 2 x 10(5) of stable cells completely converted all the input T (approximately 0.03 nmol) into DHT by 4h incubation, demonstrating that the stable cell line can be used as a cell-based assay system. Using this system, we selected the extracts of Curcumae longae rhizoma and Mori ramulus as the potential inhibitors for type II 5alpha-reductase. These results demonstrate that the type II 5alpha-reductase over-expressing stable cell line is a convenient and reliable model for screening and evaluation of inhibitors.


Subject(s)
Cholestenone 5 alpha-Reductase/metabolism , Enzyme Inhibitors/pharmacology , Base Sequence , Blotting, Western , Cell Line , Cholestenone 5 alpha-Reductase/antagonists & inhibitors , DNA Primers , Humans , Models, Theoretical , Reverse Transcriptase Polymerase Chain Reaction
12.
Phytother Res ; 21(5): 423-6, 2007 May.
Article in English | MEDLINE | ID: mdl-17236179

ABSTRACT

During the search for anticholinesterase compounds from marine organisms, two known plastoquinones, sargaquinoic acid (1) and sargachromenol (2), were isolated from Sargassum sagamianum. Both compounds showed moderate acetylcholinesterase (AChE) inhibitory activity in a micromole range (IC(50) 23.2 and 32.7 microm, respectively). However, for butyrylcholinesterase (BuChE), a new target for the treatment of Alzheimer's disease (AD), compound 1 showed particularly potent inhibitory activity (IC(50) 26 nm), which is 1000-fold greater than for AChE. Hence, sargaquinoic acid represents an effective and selective inhibitor of BuChE with a potency similar to or greater than the anticholinesterases in current clinical use, making it an interesting potential drug candidate for AD.


Subject(s)
Alkenes/pharmacology , Alzheimer Disease/drug therapy , Benzopyrans/pharmacology , Benzoquinones/pharmacology , Cholinesterase Inhibitors/pharmacology , Sargassum/chemistry , Acetylcholinesterase/chemistry , Alkenes/chemistry , Alkenes/isolation & purification , Benzopyrans/chemistry , Benzopyrans/isolation & purification , Benzoquinones/chemistry , Benzoquinones/isolation & purification , Butyrylcholinesterase/chemistry , Cholinesterase Inhibitors/chemistry , Cholinesterase Inhibitors/isolation & purification , Phytotherapy
14.
Immunopharmacol Immunotoxicol ; 26(2): 299-308, 2004 May.
Article in English | MEDLINE | ID: mdl-15209365

ABSTRACT

Black cohosh (Cimicifuga racemosa) has been used as therapeutics for pain and inflammation in Korean folk medicine. The potential effects of black cohosh extract (BCE) on mast cell-dependent allergy reaction, however, have not been well elucidated yet. In the present study, we investigated the effect of BCE on the allergy reaction using mast cell-dependent in vivo and in vitro models. BCE showed no potential of skin sensitization in local lymph node assay (LLNA). The oral administration of BCE significantly inhibited the anti-IgE-induced passive cutaneous anaphylaxis (PCA) reaction. BCE also showed inhibitory potential on the compound 48/80-induced histamine release from rat peritoneal mast cells. In addition, BCE inhibited the IL-4, IL-5 and TNF-alpha mRNA induction by PMA and A23187 in human leukemia mast cells, HMC-1. These results demonstrated that BCE has an anti-allergic potential and it may be due to the inhibition of histamine release and cytokine gene expression in the mast cells.


Subject(s)
Cimicifuga , Mast Cells/drug effects , Mast Cells/immunology , Passive Cutaneous Anaphylaxis/drug effects , Phytotherapy , Animals , Base Sequence , Calcimycin/pharmacology , Cell Line , Histamine Release/drug effects , Humans , In Vitro Techniques , Interleukin-4/genetics , Interleukin-5/genetics , Male , Mice , Mice, Inbred BALB C , Passive Cutaneous Anaphylaxis/immunology , Plant Extracts/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/genetics , p-Methoxy-N-methylphenethylamine/toxicity
15.
J Dermatol Sci ; 32(2): 143-9, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12850307

ABSTRACT

BACKGROUND: Androgens are major regulators of human hair growth, which exert their effect on follicular epithelium via the mesenchyme-derived dermal papilla (DP) cells. However, very few data are available with regard to the genes regulated by androgen in DP cells. OBJECTIVE: To investigate the differentially expressed genes by androgen in DP cells. METHODS: Human hair DP cells were cultured and transformed with SV40 T antigen. Using cDNA representational difference analysis, androgen-regulated genes in SV40-transformed dermal papilla (SDP) cells were identified. RESULTS: SDP cells revealed extended lifespan as compared with primary cultured DP cells. SDP cells expressed androgen receptor (AR) and showed androgen responsiveness. cDNA representational difference analysis followed by Northern blot analysis showed that heat shock cognate protein, Hsc70 was differentially expressed by dihydrotestosterone (DHT) treatment in SV40-transformed DP cells. CONCLUSION: These results suggest that Hsc70 may be involved in androgen action on DP cells.


Subject(s)
Androgens/physiology , Gene Expression Regulation/physiology , HSP70 Heat-Shock Proteins/genetics , Hair Follicle/physiology , Androgens/pharmacology , Cell Line, Transformed , Cell Transformation, Viral , Dihydrotestosterone/pharmacology , Gene Expression Regulation/drug effects , HSC70 Heat-Shock Proteins , Hair Follicle/cytology , Hair Follicle/metabolism , Humans , Receptors, Androgen/metabolism , Simian virus 40
16.
Int Immunopharmacol ; 3(1): 129-36, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12538043

ABSTRACT

The anti-allergic action of buckwheat grain extract (BGE) was investigated using rodent experimental models. The oral, intraperitoneal and intradermal administration of BGE significantly inhibited the compound 48/80-induced vascular permeability documented by Evans blue extravasation. In addition, BGE showed potent inhibitory effect on passive cutaneous anaphylaxis (PCA) activated by anti-dinitrophenyl (DNP) IgE when orally administered. In an in vitro study, BGE revealed to possess inhibitory potential on the compound 48/80-induced histamine release from rat peritoneal mast cells (RPMC). Moreover, BGE inhibited the IL-4 and TNF-alpha mRNA induction by PMA and A23187 in human leukemia mast cells, HMC-1. Taken together, these results suggest that anti-allergic action of BGE may be due to the inhibition of histamine release and cytokine gene expression in the mast cells.


Subject(s)
Anti-Allergic Agents/pharmacology , Fagopyrum/chemistry , Plant Extracts/pharmacology , Seeds/chemistry , Animals , Anti-Allergic Agents/administration & dosage , Anti-Allergic Agents/chemistry , Capillary Permeability/drug effects , Cell Line , Cytokines/genetics , Cytokines/metabolism , Histamine/metabolism , Humans , Male , Mast Cells/drug effects , Mast Cells/metabolism , Passive Cutaneous Anaphylaxis/drug effects , Plant Extracts/administration & dosage , Plant Extracts/chemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , p-Methoxy-N-methylphenethylamine/pharmacology
17.
J Dermatol Sci ; 30(1): 43-9, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12354419

ABSTRACT

In search of natural extracts for hair growth, we found that the extract of dried root of Sophora flavescens has outstanding hair growth promoting effect. After topical application of Sophora flavescens extract onto the back of C57BL/6 mice, the earlier conversion of telogen-to-anagen was induced. The growth of dermal papilla cells cultured in vitro, however, was not affected by Sophora flavescens extract treatment. RT-PCR analysis showed that Sophora flavescens extract induced mRNA levels of growth factors such as IGF-1 and KGF in dermal papilla cells, suggesting that the effects of Sophora flavescens extract on hair growth may be mediated through the regulation of growth factors in dermal papilla cells. In addition, the Sophora flavescens extract revealed to possess potent inhibitory effect on the type II 5alpha-reductase activity. Taken together, these results suggest that Sophora flavescens extract has hair growth promoting potential and can be used for hair growing products.


Subject(s)
Growth Substances/genetics , Hair/growth & development , Plant Extracts/pharmacology , Plant Roots/chemistry , Sophora/chemistry , Administration, Topical , Animals , Base Sequence , DNA/biosynthesis , DNA/drug effects , DNA Primers , Female , Hair/drug effects , Mice , Mice, Inbred C57BL , Plant Extracts/administration & dosage , Reverse Transcriptase Polymerase Chain Reaction , Thymidine/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...